These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15083742)

  • 1. Chlamydia pneumoniae: crossing the barriers?
    Blasi F; Centanni S; Allegra L
    Eur Respir J; 2004 Apr; 23(4):499-500. PubMed ID: 15083742
    [No Abstract]   [Full Text] [Related]  

  • 2. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature.
    Gieffers J; van Zandbergen G; Rupp J; Sayk F; Krüger S; Ehlers S; Solbach W; Maass M
    Eur Respir J; 2004 Apr; 23(4):506-10. PubMed ID: 15083745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.
    Ben-Yaakov M; Eshel G; Zaksonski L; Lazarovich Z; Boldur I
    J Clin Pathol; 2002 May; 55(5):355-8. PubMed ID: 11986341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthmatic persons are prone to the persistence of Chlamydia pneumoniae antibodies.
    Paldanius M; Juvonen R; Leinonen M; Bloigu A; Silvennoinen-Kassinen S; Saikku P
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):117-22. PubMed ID: 17572038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae infection: which role in atherosclerosis?
    Gabrielli M; Santarelli L; Gasbarrini A
    Arch Intern Med; 2002 Oct; 162(18):2140; author reply 2141. PubMed ID: 12374525
    [No Abstract]   [Full Text] [Related]  

  • 6. Seroepidemiology in Chlamydia pneumoniae-- atherosclerosis association.
    Saikku P
    Eur Heart J; 2002 Feb; 23(4):263-4. PubMed ID: 11812058
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections.
    Frikha-Gargouri O; Znazen A; Gdoura R; Gargouri B; Arab NB; Jemaa MB; Hammami A
    Pathol Biol (Paris); 2008 May; 56(3):143-7. PubMed ID: 18178034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    Clin Infect Dis; 2005 Apr; 40(8):1131-2. PubMed ID: 15791512
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of Chlamydophila pneumoniae DNA but not mRNA in stenotic aortic heart valves.
    Edvinsson M; Hjelm E; Thelin S; Friman G; Nyström-Rosander C
    Int J Cardiol; 2010 Aug; 143(1):57-62. PubMed ID: 19246110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria.
    Shima K; Coopmeiners J; Graspeuntner S; Dalhoff K; Rupp J
    FEBS Lett; 2016 Nov; 590(21):3887-3904. PubMed ID: 27509029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential hypertension is associated with Chlamydia pneumoniae but not Epstein-Barr antibodies.
    Pitiriga VC; Kotsis VT; Alexandrou MK; Petrocheilou-Paschou VD; Zakopoulou RN; Zakopoulos NA
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):924-6. PubMed ID: 12372683
    [No Abstract]   [Full Text] [Related]  

  • 12. Chlamydia pneumoniae and coronary artery disease: controversial results of serological studies.
    Yetkin G
    Int Immunopharmacol; 2006 Sep; 6(9):1524-5. PubMed ID: 16846847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.
    Bellmann-Weiler R; Martinz V; Kurz K; Engl S; Feistritzer C; Fuchs D; Rupp J; Paldanius M; Weiss G
    Immunobiology; 2010; 215(9-10):842-8. PubMed ID: 20646782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and airway remodeling.
    Hahn DL
    J Allergy Clin Immunol; 2006 May; 117(5):1193; author reply 1193-4. PubMed ID: 16675354
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute Chlamydia pneumoniae infections in asthmatic and non-asthmatic military conscripts during a non-epidemic period.
    Juvonen R; Bloigu A; Paldanius M; Peitso A; Silvennoinen-Kassinen S; Harju T; Leinonen M; Saikku P
    Clin Microbiol Infect; 2008 Mar; 14(3):207-12. PubMed ID: 18070131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma.
    Routes JM; Nelson HS; Noda JA; Simon FT
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):391-2. PubMed ID: 10669864
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia pneumoniae hides inside apoptotic neutrophils to silently infect and propagate in macrophages.
    Rupp J; Pfleiderer L; Jugert C; Moeller S; Klinger M; Dalhoff K; Solbach W; Stenger S; Laskay T; van Zandbergen G
    PLoS One; 2009 Jun; 4(6):e6020. PubMed ID: 19547701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae-based atherosclerosis: a smoking gun.
    Hoymans VY; Bosmans JM; Ieven MM; Vrints CJ
    Acta Cardiol; 2007 Dec; 62(6):565-71. PubMed ID: 18214121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
    Orfila J; Godard P
    Presse Med; 2000 Sep; 29(25):1439-41. PubMed ID: 11036523
    [No Abstract]   [Full Text] [Related]  

  • 20. Human blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae.
    Buchacher T; Wiesinger-Mayr H; Vierlinger K; Rüger BM; Stanek G; Fischer MB; Weber V
    BMC Immunol; 2014 Dec; 15():60. PubMed ID: 25488836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.